Iatrogenic Botulism: A Case Treated With Botulinum Antitoxin
Clinical Neuropharmacology, cilt.46, sa.2, ss.82-84, 2023 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 46 Sayı: 2
- Basım Tarihi: 2023
- Doi Numarası: 10.1097/wnf.0000000000000535
- Dergi Adı: Clinical Neuropharmacology
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MLA - Modern Language Association Database, Psycinfo
- Sayfa Sayıları: ss.82-84
- Anahtar Kelimeler: antitoxin, botulism, iatrogenic botulism
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Objective: Botulinum toxin type A is widely used for the treatment of spasticity, focal dystonia, hemifacial spasm, hyperhidrosis, strabismus, chronic migraine, and also cosmetic purposes. Therapeutic use is commonly effective and safe. However, if toxin enters the vascular space and gets through to peripheral cholinergic nerve terminals, it may lead to iatrogenic botulism. Method: We presented a patient who is diagnosed as iatrogenic botulism and treated with antitoxin at the 15th day of the exposure. Results: After the antitoxin administration, dramatical response to the treatment was observed. Conclusions: In this report, we want to evaluate a new case of iatrogenic botulism and emphasize the importance of antitoxin administration regardless the timing of the exposure for patients with progressing paralysis.